Sort
17,828 grants matching “crispr”
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants
$687,705Jonathan Patrick Schlebach · Purdue University · R01 · FY2023 · HL
Understanding and Targeting Transcriptional Master Regulators in Hepatocellular Carcinoma
$687,679Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2025 · CA
Mapping heritable chromatin loop variants with allele-specific Hi-C analysis
$687,518Fulai Jin · Case Western Reserve University · R01 · FY2023 · HG
Uncovering colorectal cancer etiology and biology by integrating proteomics with other omics data
$687,510Xingyi Guo · Vanderbilt University Medical Center · R01 · FY2024 · CA
Metabolic Control of Stemness in lung epithelial progenitors by FAM13A
$687,150Anny Xiaobo Zhou · Brigham And Women'S Hospital · R01 · FY2021 · HL
ePACE: an automated system for high-throughput, closed-loop control of continuous molecular evolution to enable novel therapeutics
$687,081Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2019 · EB
Epigenetic mechanisms of sustained transcription across cocaine abstinence
$686,803Elizabeth A Heller · University Of Pennsylvania · R01 · FY2022 · DA
Systematic Functional Interpretation of Regulatory Variants in Neuropsychiatric Disorders
$686,784Jubao Duan · Endeavor Health Clinical Operations · R01 · FY2023 · MH
Enzymatic Synthesis of RNA
$686,689Steven A Benner · Foundation For Applied Molecular Evolutn · R01 · FY2022 · HG
Mapping molecular pathways that control prion metabolism
$686,642Surachai Supattapone · Dartmouth College · R37 · FY2022 · NS
Finding and pushing the limits of macrophage efferocytosis in atherosclerosis
$686,640Hanrui Zhang · Columbia University Health Sciences · R35 · FY2025 · HL
Elucidating Regulation of Cell Fate Specification in Human Cortical Development to Understand Etiology of Neurodevelopment Disorders
$686,631Aparna Bhaduri · University Of California Los Angeles · R01 · FY2025 · MH
Engineering CAR-B cells for an HIV-1 functional cure
$686,549Michael R. Farzan · Boston Children'S Hospital · R01 · FY2025 · DA
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants
$686,508Jonathan Patrick Schlebach · Purdue University · R01 · FY2025 · HL
The Role of PRDM16 in Cardiac Development and Cardiomyopathy
$686,398Sihem Boudina · University Of Utah · R01 · FY2023 · HL
The Role of PRDM16 in Cardiac Development and Cardiomyopathy
$686,398Sihem Boudina · University Of Utah · R01 · FY2022 · HL
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion
$686,375Qizhi Tang · University Of California, San Francisco · R01 · FY2022 · DK
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion
$686,375Qizhi Tang · University Of California, San Francisco · R01 · FY2023 · DK
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion
$686,375Qizhi Tang · University Of California, San Francisco · R01 · FY2025 · DK
High-throughput phenotypic screening for functionally characterizing alt. exons
$686,276Thomas Gonatopoulos-Pournatzis · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Investigating the regulation of alternative splicing and its role in disease
$686,276Thomas Gonatopoulos-Pournatzis · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides
$685,879Paul B McCray · University Of Iowa · UG3 · FY2019 · HL
Leveraging Context-Specific eQTL to Inform BMD GWAS
$685,866Charles R. Farber · University Of Virginia · R01 · FY2025 · AR
Role of Extended 3' UTR isoforms in Axon Guidance
$685,823Pedro Miura · Board Of Regents, Nshe, Obo University Of Nevada, Reno · · FY2017 · BIO
Targeting natural killer cells to enhance HIV vaccine responses
$685,580Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · AI